Literature DB >> 27410460

Surgical treatment of megaduodenum in familial visceral myopathy - report of a case and review of the literature.

Davide Papis1, Gabriele Marangoni1.   

Abstract

INTRODUCTION: Familial visceral myopathy (VM) is a rare genetic disease that affects intestinal motility and results in pseudo-obstruction. Medical treatments can provide supportive measures but no curative treatment. CASE REPORT: A 20-year-old male with known diagnosis of VM was referred to our Unit in May 2013 with recurrent episodes of vomiting and hospital admissions not responding to medical treatment. Pre-operative imaging showed megaduodenum with marked delayed transit and normal small and large bowel transit. He underwent an elective Roux-en-Y duodeno-jejunostomy. The post-operative course was uneventful with complete resolution of the symptoms with a 2 years follow-up. DISCUSSION: Due to the early age of presentation, VM affects patient both psychologically and physically. Surgical treatment of megaduodenum in visceral myopathy in the absence of motility disorder of the small bowel seems to achieve satisfactory symptomatic relief and could be considered in this rare cohort of patients.

Entities:  

Keywords:  Duodeno-jejunostomy; familial visceral myopathy; megaduodenum

Mesh:

Year:  2016        PMID: 27410460     DOI: 10.1080/00015458.2016.1147263

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  2 in total

1.  A rare case of idiopathic congenital megaduodenum in adult misinterpreted during childhood: case report and literature review.

Authors:  Natally Horvat; Vicente Bohrer Brentano; Emerson Shigueaki Abe; Rodrigo Blanco Dumarco; Publio Cesar Cavalcante Viana; Marcel Cerqueira Cesar Machado
Journal:  Radiol Case Rep       Date:  2019-05-09

2.  Prenatal diagnosis of megaduodenum using ultrasound: a case report.

Authors:  Kaihui Zeng; Dongmei Li; Yao Zhang; Chengcheng Cao; Ruobing Bai; Zeyu Yang; Lizhu Chen
Journal:  BMC Pregnancy Childbirth       Date:  2021-05-11       Impact factor: 3.007

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.